Jim Simons Harrow Health, Inc. Transaction History
Renaissance Technologies LLC
- $63.6 Billion
- Q1 2024
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Harrow Health, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 477,358 shares of HROW stock, worth $9.97 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
477,358
Previous 611,180
21.9%
Holding current value
$9.97 Million
Previous $6.85 Million
7.74%
% of portfolio
0.01%
Previous 0.01%
Shares
21 transactions
Others Institutions Holding HROW
# of Institutions
123Shares Held
21.3MCall Options Held
113KPut Options Held
366K-
Opaleye Management Inc. Boston, MA3.92MShares$81.9 Million12.62% of portfolio
-
Private Capital Management, LLC Naples, FL3.01MShares$62.9 Million4.93% of portfolio
-
Black Rock Inc. New York, NY2.18MShares$45.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.83MShares$38.2 Million0.0% of portfolio
-
Morgan Stanley New York, NY953KShares$19.9 Million0.0% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $565M
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...